Published on 9 Nov 2022 on Zacks via Yahoo Finance
Treace Medical Concepts (TMCI) Reports Q3 Loss, Tops Revenue Estimates
Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.12 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 21.43%. A quarter ago, it was expected that this orthopedic medical device maker would post a loss of $0.21 per share when it actually produced a loss of $0.23, delivering a surprise of -9.52%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.